Published in Women's Health Weekly, October 21st, 2004
Fifty blood samples, including 14 from patients with cancer at varying stages of disease progression and 36 with benign breast disease or disease-free patients, were tested using two methods: an immunoassay and a recently developed qualitative reverse-transcription polymerase chain reaction (RT-PCR) procedure.
Test results were presented at the 4th Annual European Conference: Perspectives in Breast Cancer. In addition, Matritech's director of Technology Development, Jay Stoerker, gave a presentation on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly